Antiphosphatidylserine/Prothrombin Antibodies (aPS/PT) as Potential Markers of Antiphospholipid Syndrome
- 2 March 2012
- journal article
- Published by SAGE Publications in Clinical and Applied Thrombosis/hemostasis
- Vol. 19 (3), 289-296
- https://doi.org/10.1177/1076029612437578
Abstract
The antiphospholipid antibodies present in antiphospholipid syndrome (APS) are directed at a number of phospholipid-binding proteins: β2 glycoprotein I (β2GPI), prothrombin, and so on. Antibodies directed at β2GPI are accepted as a classification criterion for APS, while the presence of antiprothrombin antibodies is not. In the present article, we investigated the possible role of antiphosphatidylserine/prothrombin antibodies (aPS/PT) as marker of APS on a cohort of 295 individuals with APS (95 primary APS and 45 secondary APS) and APS-related diseases. We found aPS/PT to be highly associated with venous thrombosis (immunoglobulin G [IgG] aPS/PT odds ratio [OR], 7.44; 95% confidence interval [CI], 3.97-13.92 and IgM aPS/PT OR, 2.54; 95% CI, 1.35-4.77) and obstetric abnormalities (IgG aPS/PT OR, 2.37; 95% CI, 1.04-5.43), but not with arterial thrombosis. A very high degree of concordance between the concentration of aPS/PT and lupus anticoagulant activity was demonstrated. Therefore, we support the inclusion of aPS/PT determination as second-level assay to confirm APS classification.Keywords
This publication has 23 references indexed in Scilit:
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Antiphospholipid antibody tests: spreading the netAnnals Of The Rheumatic Diseases, 2005
- Acquired Activated Protein C Resistance Associated with IgG Antibodies against β2-Glycoprotein I and Prothrombin as a Strong Risk Factor for Venous ThromboembolismClinical Chemistry, 2005
- Antiprothrombin antibodies detected in two different assay systemsThrombosis and Haemostasis, 2005
- Antiprothombin antibodies and the diagnosis of antiphospholipid syndromeClinical Immunology, 2004
- Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndromeBlood, 2003
- Specificities, properties, and clinical significance of antiprothrombin antibodiesArthritis & Rheumatism, 2003
- Hypercoagulability SyndromesArchives of Internal Medicine, 2001
- Should we Include Anti-prothrombin Antibodies in the Screening for the Antiphospholipid Syndrome?Journal of Autoimmunity, 2000
- PHOSPHATTDYL SERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODY IS EXCLUSIVE TO PATIENTS WITH LUPUS ANTICOAGULANTRheumatology, 1996